NPF
OPK icon

Norris Perne & French’s Opko Health OPK Stock Holding History

Norris Perne & French’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,000
Closed -$49.6K – 171
2025
Q3 		$49.6K Hold
32,000
– – ﹤0.01% 164
2025
Q2 		$42.2K Hold
32,000
– – ﹤0.01% 153
2025
Q1 		$53.1K Buy
32,000
+2,000
+7% +$3.29K ﹤0.01% 143
2024
Q4 		$44.1K Buy
30,000
+3,000
+11% +$4.59K ﹤0.01% 142
2024
Q3 		$40.2K Buy
27,000
+2,000
+8% +$2.97K ﹤0.01% 145
2024
Q2 		$31.3K Hold
25,000
– – ﹤0.01% 143
2024
Q1 		$30K Hold
25,000
– – ﹤0.01% 145
2023
Q4 		$37.8K Hold
25,000
– – ﹤0.01% 135
2023
Q3 		$40K Hold
25,000
– – ﹤0.01% 128
2023
Q2 		$54.3K Buy
25,000
+5,000
+25% +$7.82K ﹤0.01% 130
2023
Q1 		$29.2K Sell
20,000
-37,000
-65% -$47.6K ﹤0.01% 133
2022
Q4 		$71.3K Sell
57,000
-9,000
-14% -$14.2K 0.01% 136
2022
Q3 		$125K Hold
66,000
– – 0.01% 129
2022
Q2 		$167K Sell
66,000
-1,000
-1% -$2.92K 0.02% 132
2022
Q1 		$230K Hold
67,000
– – 0.02% 141
2021
Q4 		$322K Hold
67,000
– – 0.03% 114
2021
Q3 		$245K Buy
67,000
+7,000
+12% +$26.1K 0.02% 125
2021
Q2 		$243K Hold
60,000
– – 0.02% 125
2021
Q1 		$257K Buy
60,000
+500
+0.8% +$2.39K 0.02% 114
2020
Q4 		$235K Buy
59,500
+7,000
+13% +$29.2K 0.02% 146
2020
Q3 		$194K Buy
52,500
+500
+1% +$2.11K 0.02% 146
2020
Q2 		$177K Buy
52,000
+18,500
+55% +$41.4K 0.02% 133
2020
Q1 		$45K Buy
33,500
+20,000
+148% +$31.3K 0.01% 113
2019
Q4 		$20K Buy
+13,500
New +$22.6K ﹤0.01% 142
2017
Q4 		– Sell
-10,100
Closed -$69K – 154
2017
Q3 		$69K Buy
+10,100
New +$63.7K 0.01% 152

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norris Perne & French's OPK Position: Q4 2025 in Review

Norris Perne & French sold out of Opko Health (OPK) in Q4 2025, closing a stake of 32,000 shares — an estimated $49.6K sold.

Norris Perne & French first reported a position in OPK in Q3 2017 and held it in 25 quarters. The position peaked at $322K in Q4 2021. 220 funds tracked by Wall St. Rank hold OPK as of Q4 2025.

  • Norris Perne & French reported no remaining Opko Health position as of Q4 2025 after selling out during the quarter.
  • Norris Perne & French sold 32,000 Opko Health shares in Q4 2025, an estimated $49.6K.
  • Norris Perne & French first reported a position in Opko Health in Q3 2017 and held it in 25 quarters.
  • Norris Perne & French's Opko Health position peaked at $322K in Q4 2021.
  • 220 funds tracked by Wall St. Rank held Opko Health as of Q4 2025.

Based on Norris Perne & French's 13F filing for Q4 2025, filed 23 Jan 2026.